BallA. P.: Clavulanic acid and amoxycillin: a clinical, bacteriological and pharmacological study. Lancet, 22; 620 (1980).
2.
BallA. P.: Clinical efficacy and tolerance of Augmentin in soft tissue infection. J. Antimicrob. Chemother., 10; 67 (1982).
3.
BeeuwkesH., RutgersV. H.: A combination of amoxycillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxycillin resistant Haemophilus influenzae. Infection, 9; 244 (1981).
4.
BrodgenR. N.: Amoxycillin-clavulanic acid: a review of its antibacterial activity, pharmacokinetic and therapeutic use. Drugs, 22; 337 (1981).
5.
BrownA. G., ButterworthD., ColeM., HanscombG., HoodJ. D., ReadingC., RolisonG. N.: Naturally occuring beta-lactamases inhibitors with antibacterial activity. J. Antimicrob., 29; 668 (1976).
6.
GoldsteinF. W.: Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. J. Antimicrob. Chemother., 5; 705 (1979).
7.
IravaniA., RichatdG. A.: Treatment of urinary tract infections with a combination of amoxycillin and clavulanic acid. Antimicrob. Agents Chemother., 22; 672 (1982).
8.
JacksonD., StaniforthD. H.: Augmentin: a new approach to antibacterial chemotherapy - a review. Acta Ther., 8; 367 (1982).
9.
MartinelliR.: Amoxycillin-clavulanic acid in the treatment of urinary tract infection due to Gram-negative bacteria resistant to penicillin. Antimicrob. Agents Chemother., 20; 800 (1981).
UlmerW. T., ZimmermannI.: A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis. J. Intern. Med. Res., 9; 372 (1983).
